D 01
Pill imprint D 01 has been identified as Zidovudine 100 mg.
Zidovudine is used in the treatment of hiv infection; occupational exposure; nonoccupational exposure; reduction of perinatal transmission of hiv and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy.
Zidovudine 100 mg is not subject to the Controlled Substances Act.
See also related documents.
Zidovudine Images
- Imprint:
-
D
01 - Strength:
- 100 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Inactive Ingredients:
- microcrystalline cellulose
corn starch
sodium starch glycolate type A potato
magnesium stearate
ferrosoferric oxide
shellac
titanium dioxide
sodium lauryl sulfate
gelatin
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Aurobindo Pharma
- National Drug Code (NDC):
- 65862-0107
| NDC Code | Manufacturer / Repackager |
|---|---|
| 68084-0461 | Amerisource Health Services |
Note: Inactive ingredients may vary.
Submitted by: iTunespy
Advertisement
More Zidovudine resources
- Zidovudine (Wolters Kluwer)
- Zidovudine Capsules (Wolters Kluwer)
- Zidovudine Syrup (Wolters Kluwer)
- zidovudine (Cerner Multum)
- zidovudine injection (Cerner Multum)
- zidovudine (Micromedex) - Includes Dosage Information
- zidovudine Intravenous (Micromedex) - Includes Dosage Information
- Zidovudine (AHFS DI)
- Retrovir Infusion (FDA)
- Zidovudine (FDA)
- Zidovudine Oral Solution (FDA)
- Zidovudine Tablets (FDA)
- Zidovudine (Azidothymidine; AZT; Compound S) (Wolters Kluwer)
Search Again
